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The extracellular matrix (ECM) forms the basis of every phase in wound healing. Healing may be impaired if some of these
components are destroyed. Photobiostimulation has demonstrated a stimulatory response in biological processes.This study aimed
to evaluate various genes involved in the ECM, in response to laser irradiation. Isolated human skin fibroblasts were used in
three different cell models, namely, normal, normal wounded, and diabetic wounded. Cells were irradiated with 5 J/cm2 using
a continuous wave diode laser emitting at a wavelength of 660 nm and incubated for 48 h. Nonirradiated (0 J/cm2) normal and
diabetic wounded cells served as the control. Real-time reverse transcription (RT) quantitative polymerase chain reaction (qPCR)
was used to determine the expression of 84 genes in a PCR array.There was a significant upregulation of 29 genes in the normal cells,
32 genes in the normal wounded cells, and 18 genes in the diabetic wounded cells as well as a downregulation of 19 genes (normal),
6 genes (normal wounded), and 31 genes (diabetic wounded). Low intensity laser irradiation (LILI) stimulates gene expression in
various cell adhesion molecules (CAMs) and extracellular proteins at 660 nm in wounded fibroblasts in vitro.
1. Introduction
Components of the extracellular matrix (ECM) have been
shown to be useful in wound healing [1, 2]. They form the
core of every wound healing phase, and healing may be
impaired if any of these components is destroyed [3]. In
addition, they play a role in angiogenesis, tissue remodelling,
and rapid scaffold breakdown [4]. The interaction between
the ECM and various cells is very important for proper
functioning of the cell [5–8]. This interaction could be direct
or indirect. Directly, cellular receptors stimulate the ECM or
indirectly, through the structural components of the ECM
produced by glycoproteins. Cellular activities directed by
these interactions are required for wound healing.
Regulation of the wound healing process comprises
the interaction of various cell types, namely, neutrophils,
lymphocytes, macrophages, and fibroblasts, and regular
mediators such as growth factors and cytokines and ECM
components (fibronectin (FN); fibrin; collagen; and elastin
(EI)); laminin (LMN); proteoglycans (PG); glycosaminogly-
cans (GAG); matrix metalloproteinases (MMPs); and tissue
inhibitor of metalloproteinases (TIMPs) [2].
For proper cell survival and gene expression in normal
wound healing, the environment needs to be at equilibrium
with the activity of growth factors, fibroblast interaction,
and mechanical forces to ensure normal tissue remodelling
[9]. Fibroblasts produce most of the molecules in the ECM
including proteases, integrins, cytokines, and growth factors
during tissue repair which are responsible for late phase tissue
remodelling and eventually scarring [10, 11]. However, the
situation is different in chronic wounds due to the disruption
of the regular healing process because of tissue damage,
biochemical and cellular imbalances, or an underlying patho-
logical state such as diabetes and venous insufficiency.Venous
leg ulcers (VLUs) are amongst the major problems in public
health and have become an economic burden in most health
care services. It is commonly associated with pain, reduces
the quality of life, and is even associated with death. It may
also cause tiredness and depression [12–14]. The prevalence
of diabetic foot ulcers is approximately 1-2% worldwide [15];
it occurs at any age [16] with an incidence of 3–5% over 65
years [17].
Photobiostimulation, or photobiomodulation, is a non-
invasive type of treatment that modulates the treatment of
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Table 1: Laser parameters.
Laser parameters
Wavelength (nm) 660
Wave emission Continuous wave
Power output (mW) 92.5
Spot size (cm2) 9.1
Output density (mW/cm2) 10.22
Irradiation duration 8min 9 s
Fluence (J/cm2) 5
Table 2: Functional genes of the ECM and its adhesion molecules.
Pathway Genes
Cell adhesion molecules
Transmembrane molecules
CD44, CDH1, HAS1, ICAM1, ITGA1, ITGA2, ITGA3, ITGA4, ITGA5, ITGA6, ITGA7, ITGA8, ITGAL,
ITGAM, ITGAV, ITGB1, ITGB2, ITGB3, ITGB4, ITGB5, MMP14, MMP15, MMP16, NCAM1, PECAM1,
SELE, SELL, SELP, SGCE, SPG7, and VCAM1
Cell-cell adhesion CD44, CDH1, COL11A1, COL14A1, COL6A2, CTNND1, ICAM1, ITGA8, and VCAM1
Cell-matrix adhesion ADAMTS13, CD44, ITGA1, ITGA2, ITGA3, ITGA4, ITGA5, ITGA6, ITGA7, ITGA8, ITGAL, ITGAM,ITGAV, ITGB1, ITGB2, ITGB3, ITGB4, ITGB5, SGCE, SPP1, and THBS3
Other adhesion molecules
CNTN1, COL12A1, COL15A1, COL16A1, COL5A1, COL6A1, COL7A1, COL8A1, VCAN, CTGF, CTNNA1,
CTNNB1, CTNND2, FN1, KAL1, LAMA1, LAMA2, LAMA3, LAMB1, LAMB3, LAMC1, THBS1, THBS2,
CLEC3B, TNC, and VTN
Extracellular matrix proteins
Basement membrane
constituents COL4A2, COL7A1, LAMA1, LAMA2, LAMA3, LAMB1, LAMB3, LAMC1, and SPARC
Collagens and ECM
structural constituents
COL11A1, COL12A1, COL14A1, COL15A1, COL16A1, COL1A1, COL4A2, COL5A1, COL6A1, COL6A2,
COL7A1, COL8A1, FN1, and KAL1
ECM proteases ADAMTS1, ADAMTS13, ADAMTS8, MMP1, MMP10, MMP11, MMP12, MMP13, MMP14, MMP15,MMP16, MMP2, MMP3, MMP7, MMP8, MMP9, SPG7, and TIMP1
ECM protease inhibitors COL7A1, KAL1, THBS1, TIMP1, TIMP2, and TIMP3
Other ECMmolecules VCAN, CTGF, ECM1, HAS1, SPP1, TGFBI, THBS2, THBS3, CLEC3B, TNC, and VTN
wounds through various cellular or biological processes. It is
effective in the visible and near infrared (NIR) spectral range.
It functions at wavelengths of 500–1 100 nm and a power
output of 10–200mW [18]. The use of photobiomodulation
in wound healing has greatly ameliorated various cellular
processes affecting different phases of wound healing. Studies
have demonstrated the stimulatory effects of photobiomodu-
lation in wounded cell models [19] at 660 nm [20]. Studies
have also shown that it enhances diabetic wound healing
in both rats and mice [21–23]. Photobiostimulation in the
visible and NIR spectral range has been demonstrated to
regulate gene expression in human and animal cell cultures,
even though its effect was not consistent in all irradiated cells
[24]. Studies from different areas showed variations in the
gene expression profile of 50 cultures of fibroblasts [25]. Few
studies have exploited the relationship of laser irradiation and
gene expression of the ECM in fibroblasts in vitro. Due to
previous studies which showed an increase in collagen type
I (Col-I) in response to laser irradiation at 660 nm [20], this
study aimed to determine the effect of laser irradiation at
660 nm on the gene expression profile of the ECM and its cell
adhesion molecules.
2. Methodology
2.1. Cell Culture. This study was performed on human skin
fibroblasts isolated from a consenting adult undergoing
abdominoplasty (Linksfield, Sandringham, Johannesburg)
(University of Johannesburg Academic Ethics Committee
Clearance Reference number 01/06). Cells were seeded into
3.4 cm diameter tissue culture flasks at a density of 6 × 105
and routinely cultured according to standard techniques [26].
Different cell models, namely, normal (N), normal wounded
(NW), and diabetic wounded (DW), were used. To establish
an in vitro diabetic model, 17mM/L D-glucose was added
to the media with a base concentration of 5.6mM/L D-
glucose. Thirty minutes prior to irradiation, a sterile 1mL
disposable pipette was used to scratch the monolayer of cells
in a streaking motion (i.e., creating a central scratch (CS)).
This creates a cell-free zone on either side of the central
scratch [27, 28].
2.2. Laser Irradiation. Cells were irradiated with 5 J/cm2
using a continuous wave diode laser emitting at a wavelength
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Table 3: Gene expression profile in normal (N) cells irradiated at 660 nm. Total RNA from nonirradiated N cells and irradiated N cells
were characterised in triplicate. A fold difference >1 is considered as gene upregulation, while a fold difference <1 is considered as gene
downregulation. Fold differences are indicated as upregulation (↑) or downregulation (↓). X denotes the nonsignificant genes in that particular
cell model.
Gene symbol Gene description Gene ID Fold difference Up/downregulation P value
ADAMTS1 ADAMmetallopeptidase with thrombospondintype 1 motif, 1 9510 4.36 ↑ 0.003
ADAMTS13 ADAMmetallopeptidase with thrombospondintype 1 motif, 13 11093 1.32 X 0.259
ADAMTS8 ADAMmetallopeptidase with thrombospondintype 1 motif, 8 11095 2.77 ↑ 0.003
CD44 CD44 molecule (Indian blood group) 960 4.85 ↑ 0.012
CDH1 Cadherin 1, type 1, E-cadherin (epithelial) 999 0.58 ↓ 0.019
CLEC3B C-type lectin domain family 3, member B 7123 1.90 X 0.078
CNTN1 Contactin 1 1272 1.14 X 0.547
COL11A1 Collagen, type XI, alpha 1 1301 1.05 X 0.896
COL12A1 Collagen, type XII, alpha 1 1303 2.21 ↑ 0.003
COL14A1 Collagen, type XIV, alpha 1 7373 0.56 X 0.116
COL15A1 Collagen, type XV, alpha 1 1306 1.33 X 0.198
COL16A1 Collagen, type XVI, alpha 1 1307 1.57 X 0.074
COL1A1 Collagen, type I, alpha 1 1277 1.88 ↑ 0.001
COL4A2 Collagen, type IV, alpha 2 1284 1.78 ↑ 0.022
COL5A1 Collagen, type V, alpha 1 1289 4.23 ↑ 0.001
COL6A1 Collagen, type VI, alpha 1 1291 2.42 ↑ 0.010
COL6A2 Collagen, type VI, alpha 2 1292 3.99 ↑ 0.000
COL7A1 Collagen, type VII, alpha 1 1294 1.13 X 0.658
COL8A1 Collagen, type VIII, alpha 1 1295 3.07 ↑ 0.000
CTGF Connective tissue growth factor 1490 0.43 ↓ 0.002
CTNNA1 Catenin (cadherin-associated protein), alpha 1,102 kDa 1495 0.73 ↓ 0.039
CTNNB1 Catenin (cadherin-associated protein), beta 1,88 kDa 1499 1.27 X 0.153
CTNND1 Catenin (cadherin-associated protein), delta 1 1500 2.21 ↑ 0.001
CTNND2 Catenin (cadherin-associated protein), delta 2(neural plakophilin-related arm-repeat protein) 1501 0.09 ↓ 0.002
ECM1 Extracellular matrix protein 1 1893 0.47 ↓ 0.000
FN1 Fibronectin 1 2335 2.29 ↑ 0.005
HAS1 Hyaluronan synthase 1 3036 1.20 X 0.182
ICAM1 Intercellular adhesion molecule 1 3383 0.72 X 0.156
ITGA1 Integrin, alpha 1 3672 1.88 ↑ 0.002
ITGA2 Integrin, alpha 2 (CD49B, alpha 2 subunit ofVLA-2 receptor) 3673 0.99 X 0.650
ITGA3 Integrin, alpha 3 (antigen CD49C, alpha 3 subunitof VLA-3 receptor) 3675 2.98 ↑ 0.000
ITGA4 Integrin, alpha 4 (antigen CD49D, alpha 4 subunitof VLA-4 receptor) 3676 0.81 X 0.193
ITGA5 Integrin, alpha 5 (fibronectin receptor, alphapolypeptide) 3678 3.26 ↑ 0.000
ITGA6 Integrin, alpha 6 3655 1.21 X 0.085
ITGA7 Integrin, alpha 7 3679 0.92 X 0.780
ITGA8 Integrin, alpha 8 8516 1.06 X 0.805
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Table 3: Continued.
Gene symbol Gene description Gene ID Fold difference Up/downregulation P value
ITGAL
Integrin, alpha L (antigen CD11A (p180),
lymphocyte function-associated antigen 1; alpha
polypeptide)
3683 1.06 X 0.540
ITGAM Integrin, alpha M (complement component 3receptor 3 subunit) 3684 1.58 X 0.055
ITGAV Integrin, alpha V (vitronectin receptor, alphapolypeptide, antigen CD51) 3685 1.17 X 0.331
ITGB1
Integrin, beta 1 (fibronectin receptor, beta
polypeptide, antigen CD29 includes MDF2,
MSK12)
3688 0.92 X 0.459
ITGB2 Integrin, beta 2 (complement component 3receptor 3 and 4 subunit) 3689 0.96 X 0.792
ITGB3 Integrin, beta 3 (platelet glycoprotein IIIa, antigenCD61) 3690 1.08 X 0.339
ITGB4 Integrin, beta 4 3691 1.25 X 0.127
ITGB5 Integrin, beta 5 3693 1.05 X 0.672
KAL1 Kallmann syndrome 1 sequence 3730 1.53 ↑ 0.030
LAMA1 Laminin, alpha 1 284217 0.52 ↓ 0.001
LAMA2 Laminin, alpha 2 3908 0.52 ↓ 0.008
LAMA3 Laminin, alpha 33909 3909 2.60 ↑ 0.023
LAMB1 Laminin, beta 1 3912 0.92 X 0.594
LAMB3 Laminin, beta 3 3914 0.55 X 0.069
LAMC1 Laminin, gamma 1 (formerly LAMB2) 3915 0.83 X 0.063
MMP1 Matrix metallopeptidase 1 (interstitialcollagenase) 4312 0.41 ↓ 0.001
MMP10 Matrix metallopeptidase 10 (stromelysin 2) 4319 0.81 X 0.198
MMP11 Matrix metallopeptidase 11 (stromelysin 3) 4320 1.53 ↑ 0.015
MMP12 Matrix metallopeptidase 12 (macrophage elastase) 4321 0.48 ↓ 0.010
MMP13 Matrix metallopeptidase 13 (collagenase 3) 4322 0.42 ↓ 0.001
MMP14 Matrix metallopeptidase 14 (membrane-inserted) 4323 4.14 ↑ 0.000
MMP15 Matrix metallopeptidase 15 (membrane-inserted) 4324 1.96 ↑ 0.000
MMP16 Matrix metallopeptidase 16 (membrane-inserted) 4325 1.11 X 0.186
MMP2 Matrix metallopeptidase 2 (gelatinase A, 72 kDagelatinase, 72 kDa type IV collagenase) 4313 3.34 ↑ 0.000
MMP3 Matrix metallopeptidase 3 (stromelysin 1,progelatinase) 4314 0.23 ↓ 0.007
MMP7 Matrix metallopeptidase 7 (matrilysin, uterine) 4316 0.62 ↓ 0.045
MMP8 Matrix metallopeptidase 8 (neutrophilcollagenase) 4317 0.75 X 0.112
MMP9 Matrix metallopeptidase 9 (gelatinase B, 92 kDagelatinase, 92 kDa type IV collagenase) 4318 0.39 ↓ 0.013
NCAM1 Neural cell adhesion molecule 1 4684 1.63 ↑ 0.027
PECAM1 Platelet/endothelial cell adhesion molecule 5175 0.81 X 0.503
SELE Selectin E 6401 0.93 X 0.568
SELL Selectin L 6402 0.99 X 0.961
SELP Selectin P (granule membrane protein 140 kDa,antigen CD62) 6403 1.35 X 0.469
SGCE Sarcoglycan, epsilon 8910 0.36 ↓ 0.004
SPARC Secreted protein, acidic, cysteine-rich(osteonectin) 6678 3.33 ↑ 0.000
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Table 3: Continued.
Gene symbol Gene description Gene ID Fold difference Up/downregulation P value
SPG7 Spastic paraplegia 7 (pure and complicatedautosomal recessive) 6687 5.12 ↑ 0.000
SPP1 Secreted phosphoprotein 1 6696 0.55 ↓ 0.001
TGFBI Transforming growth factor, beta-induced, 68 kDa 7045 0.87 X 0.361
THBS1 Thrombospondin 1 7057 1.87 ↑ 0.006
THBS2 Thrombospondin 2 7058 2.65 ↑ 0.003
THBS3 Thrombospondin 3 7059 1.20 X 0.235
TIMP1 TIMP metallopeptidase inhibitor 1 7076 1.43 ↑ 0.035
TIMP2 TIMP metallopeptidase inhibitor 2 7077 1.17 ↑ 0.025
TIMP3 TIMP metallopeptidase inhibitor 3 7078 0.43 ↓ 0.008
TNC Tenascin C 3371 0.49 ↓ 0.002
VCAM1 Vascular cell adhesion molecule 1 7412 0.38 ↓ 0.010
VCAN Versican 1462 0.46 ↓ 0.008
VTN Vitronectin 7448 1.12 X 0.585
of 660 nm (Fremont, CA, USA, RGBlase, TECIRL-100G-
650SMA); laser parameters are shown in Table 1. All lasers
were supplied and set up by the National Laser Centre
(NLC) of the Council for Scientific and Industrial Research
(CSIR), South Africa. Nonirradiated (0 J/cm2) normal cells
(for irradiated normal and normal wounded) and diabetic
wounded cells (for irradiated diabetic wounded cells) served
as the control groups. Cells were irradiated from above, with
the culture dish lid off, in 1mL culture media and in the dark
to omit nuisance variables suggestive of polychromatic light
that would interfere with the laser effect. The power output
was measured using a power meter (FieldMate, 0398D05) at
bench level prior to each irradiation, and the readings were
used to determine the irradiation time. The temperature of
the culture media during irradiation was measured every
2min and remained less than 32∘C. Cells were incubated for
48 h, and the profile of genes involved in the ECM and cell
adhesion molecules were assessed using a real-time reverse
transcription quantitative polymerase chain reaction (RT-
qPCR) array.
2.3. RNA Isolation and Purity. Isolation of total RNA from
the cells was performed on the Qiagen QIAcube (Whitehead
Scientific, Cape Town, South Africa) using the RNeasy Mini
Kit (Whitehead Scientific, Cape Town, South Africa, Qiagen,
74104) including QIAshredder homogenizers (Whitehead
Scientific, Cape Town, South Africa, Qiagen, 79654). After
incubation, cell cultures were detached with TrypLE Express
(1mL/25 cm2) (Life Technologies, Gibco, Invitrogen, 12605-
021) and washed with phosphate buffered saline (PBS) to
eliminate traces of culture media and then resuspended in
600𝜇L of a guanidine-thiocyanate-containing buffer (RLT
buffer) to disrupt the cells, inactivate RNases, and release
cellular contents. Within 30min, 30 𝜇L of total RNA was
eluted and quantified. The concentration of RNA was estab-
lished using the Quant-iT RNA Assay Kits (Life Technolo-
gies, Johannesburg, South Africa, Invitrogen, Q32852) with
the Invitrogen Qubit 2.0 fluorometer (Life Technologies,
Johannesburg, South Africa). The ratio between absorbance
260 and 280 nm (A
260
nm/A
280
nm) was used to estimate
the sample purity using a UV/Vis spectrophotometer (Sep-
aration Scientific, Johannesburg, South Africa, PerkinElmer,
Victor3).
2.4. cDNA Synthesis. According to the protocol, a two-
step procedure was used to synthesise cDNA using the
QuantiTect Reverse Transcription Kit (Whitehead Scientific,
Cape Town, South Africa, Qiagen, 205311). Traces of possible
contaminating genomic DNA (gDNA) was eliminated from
1 𝜇g purified RNA sample using the gDNA Wipeout Buffer
for 2 min at 42∘C. RNA was then reverse-transcribed using a
reverse transcription (RT) master mix. Six microliters of RT
master mix was added to the reaction mixture to give a final
volume of 20 𝜇L. The mixture was then incubated for 30min
at 42∘C and thereafter 3min at 95∘C to terminate the reaction.
One microliter of sample was used to estimate the purity as
stated earlier. Samples were stored on ice to proceed directly
with real-time qPCR or stored at −20∘C.
2.5. Gene Expression Profiling. Real-time qPCR was per-
formed using the SABiosciences RT2 profiler PCR array
(Whitehead Scientific, Cape Town, South Africa, PAHS-
01321Z) which profiled 84 genes (Table 2). Ninety-twomicro-
liters of PCR water (Diethyl Pyrocarbonate, DEPC free) was
added to thawed cDNA (19 𝜇L) giving a final volume of
111 𝜇L. One hundred and two microliters of diluted cDNA
was added to the ready-to-use 2x SABiosciences RT2 qPCR
master mix (330521), and then 1 248𝜇L of PCR water was
added to give a total volume of 2 700𝜇L. Components were
mixed and 25 𝜇L of the experimental cocktail was dispensed
into each well of the 96-well plate.The sealed PCR plates were
centrifuged at 1000 g (Separation Scientific, Johannesburg,
South Africa, Thermo Scientific, Heraeus Labofuge 400) for
1min to remove any bubbles and run in the preset real-time
thermocycler (Anatech, Randburg, South Africa, Stratagene
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Table 4: Gene expression profile in normal wounded (NW) cells irradiated at 660 nm. Total RNA from nonirradiated N cells and irradiated
NW cells were characterised in triplicate. A fold difference >1 is considered as gene upregulation, while a fold difference <1 is considered as
gene downregulation. Fold differences are indicated as upregulation (↑) or downregulation (↓). X denotes the nonsignificant genes in that
particular cell model.
Gene symbol Gene description Gene ID Fold difference Up/downregulation P value
ADAMTS1 ADAMmetallopeptidase with thrombospondin type 1motif, 1 9510 1.86 ↑ 0.045
ADAMTS13 ADAMmetallopeptidase with thrombospondin type 1motif, 13 11093 2.39 ↑ 0.003
ADAMTS8 ADAMmetallopeptidase with thrombospondin type 1motif, 8 11095 1.85 ↑ 0.001
CD44 CD44 molecule (Indian blood group) 960 1.25 X 0.356
CDH1 Cadherin 1, type 1, E-cadherin (epithelial) 999 1.23 X 0.205
CLEC3B C-type lectin domain family 3, member B 7123 1.15 X 0.299
CNTN1 Contactin 1 1272 1.25 X 0.068
COL11A1 Collagen, type XI, alpha 1 1301 1.04 X 0.854
COL12A1 Collagen, type XII, alpha 1 1303 1.69 ↑ 0.004
COL14A1 Collagen, type XIV, alpha 1 7373 0.81 X 0.370
COL15A1 Collagen, type XV, alpha 1 1306 1.20 X 0.216
COL16A1 Collagen, type XVI, alpha 1 1307 1.05 X 0.749
COL1A1 Collagen, type I, alpha 1 1277 1.45 ↑ 0.006
COL4A2 Collagen, type IV, alpha 2 1284 1.44 X 0.069
COL5A1 Collagen, type V, alpha 1 1289 1.61 ↑ 0.005
COL6A1 Collagen, type VI, alpha 1 1291 1.27 X 0.170
COL6A2 Collagen, type VI, alpha 2 1292 1.36 X 0.105
COL7A1 Collagen, type VII, alpha 1 1294 1.42 ↑ 0.005
COL8A1 Collagen, type VIII, alpha 1 1295 1.36 ↑ 0.011
CTGF Connective tissue growth factor 1490 0.95 X 0.284
CTNNA1 Catenin (cadherin-associated protein), alpha 1, 102 kDa 1495 1.03 X 0.720
CTNNB1 Catenin (cadherin-associated protein), beta 1, 88 kDa 1499 0.95 X 0.700
CTNND1 Catenin (cadherin-associated protein), delta 1 1500 1.36 X 0.105
CTNND2 Catenin (cadherin-associated protein), delta 2 (neuralplakophilin-related arm-repeat protein) 1501 0.63 ↓ 0.019
ECM1 Extracellular matrix protein 1 1893 0.75 ↓ 0.017
FN1 Fibronectin 1 2335 1.63 ↑ 0.012
HAS1 Hyaluronan synthase 1 3036 2.00 ↑ 0.005
ICAM1 Intercellular adhesion molecule 1 3383 0.78 X 0.139
ITGA1 Integrin, alpha 1 3672 1.57 ↑ 0.005
ITGA2 Integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2receptor) 3673 0.86 X 0.073
ITGA3 Integrin, alpha 3 (antigen CD49C, alpha 3 subunit ofVLA-3 receptor) 3675 1.33 X 0.121
ITGA4 Integrin, alpha 4 (antigen CD49D, alpha 4 subunit ofVLA-4 receptor) 3676 1.19 X 0.057
ITGA5 Integrin, alpha 5 (fibronectin receptor, alphapolypeptide) 3678 1.46 ↑ 0.021
ITGA6 Integrin, alpha 6 3655 1.55 ↑ 0.016
ITGA7 Integrin, alpha 7 3679 0.90 X 0.462
ITGA8 Integrin, alpha 8 8516 2.94 ↑ 0.012
ITGAL Integrin, alpha L (antigen CD11A (p180), lymphocytefunction-associated antigen 1; alpha polypeptide) 3683 3683 2.04 ↑ 0.030
ITGAM Integrin, alpha M (complement component 3 receptor 3subunit) 3684 3684 1.59 ↑ 0.027
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Table 4: Continued.
Gene symbol Gene description Gene ID Fold difference Up/downregulation P value
ITGAV Integrin, alpha V (vitronectin receptor, alphapolypeptide, antigen CD51) 3685 1.43 ↑ 0.013
ITGB1 Integrin, beta 1 (fibronectin receptor, beta polypeptide,antigen CD29 includes MDF2, MSK12) 3688 1.05 X 0.652
ITGB2 Integrin, beta 2 (complement component 3 receptor 3and 4 subunit) 3689 1.17 X 0.259
ITGB3 Integrin, beta 3 (platelet glycoprotein IIIa, antigenCD61) 3690 1.53 ↑ 0.007
ITGB4 Integrin, beta 4 3691 1.42 X 0.062
ITGB5 Integrin, beta 5 3693 1.07 X 0.539
KAL1 Kallmann syndrome 1 sequence 3730 1.41 ↑ 0.006
LAMA1 Laminin, alpha 1 284217 0.81 X 0.096
LAMA2 Laminin, alpha 2 3908 1.01 X 0.921
LAMA3 Laminin, alpha 33909 3909 1.33 X 0.546
LAMB1 Laminin, beta 1 3912 1.18 X 0.113
LAMB3 Laminin, beta 3 3914 0.87 X 0.273
LAMC1 Laminin, gamma 1 (formerly LAMB2) 3915 0.94 X 0.419
MMP1 Matrix metallopeptidase 1 (interstitial collagenase) 4312 0.53 ↓ 0.011
MMP10 Matrix metallopeptidase 10 (stromelysin 2) 4319 1.06 X 0.456
MMP11 Matrix metallopeptidase 11 (stromelysin 3) 4320 1.60 ↑ 0.009
MMP12 Matrix metallopeptidase 12 (macrophage elastase) 4321 0.75 X 0.019
MMP13 Matrix metallopeptidase 13 (collagenase 3) 4322 0.78 X 0.075
MMP14 Matrix metallopeptidase 14 (membrane-inserted) 4323 0.97 X 0.909
MMP15 Matrix metallopeptidase 15 (membrane-inserted) 4324 2.66 ↑ 0.000
MMP16 Matrix metallopeptidase 16 (membrane-inserted) 4325 1.00 X 0.963
MMP2 Matrix metallopeptidase 2 (gelatinase A, 72 kDagelatinase, 72 kDa type IV collagenase) 4313 1.52 ↑ 0.004
MMP3 Matrix metallopeptidase 3 (stromelysin 1, progelatinase) 4314 0.33 ↓ 0.005
MMP7 Matrix metallopeptidase 7 (matrilysin, uterine) 4316 1.15 X 0.499
MMP8 Matrix metallopeptidase 8 (neutrophil collagenase) 4317 1.53 ↑ 0.049
MMP9 Matrix metallopeptidase 9 (gelatinase B, 92 kDagelatinase, 92 kDa type IV collagenase) 4318 1.02 X 0.803
NCAM1 Neural cell adhesion molecule 1 4684 1.09 X 0.475
PECAM1 Platelet/endothelial cell adhesion molecule 5175 2.24 ↑ 0.009
SELE Selectin E 6401 1.39 ↑ 0.041
SELL Selectin L 6402 1.08 X 0.597
SELP Selectin P (granule membrane protein 140 kDa, antigenCD62) 6403 1.47 ↑ 0.032
SGCE Sarcoglycan, epsilon 8910 0.73 ↓ 0.034
SPARC Secreted protein, acidic, cysteine-rich (osteonectin) 6678 1.59 ↑ 0.001
SPG7 Spastic paraplegia 7 (pure and complicated autosomalrecessive) 6687 1.28 ↑ 0.042
SPP1 Secreted phosphoprotein 1 6696 0.84 X 0.118
TGFBI Transforming growth factor, beta-induced, 68 kDa 7045 1.10 X 0.317
THBS1 Thrombospondin 1 7057 1.59 ↑ 0.008
THBS2 Thrombospondin 2 7058 2.04 ↑ 0.004
THBS3 Thrombospondin 3 7059 0.89 X 0.349
TIMP1 TIMP metallopeptidase inhibitor 1 7076 1.31 X 0.073
TIMP2 TIMP metallopeptidase inhibitor 2 7077 1.07 X 0.244
TIMP3 TIMP metallopeptidase inhibitor 3 7078 0.89 X 0.340
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Table 4: Continued.
Gene symbol Gene description Gene ID Fold difference Up/downregulation P value
TNC Tenascin C 3371 0.73 ↓ 0.005
VCAM1 Vascular cell adhesion molecule 1 7412 0.61 X 0.065
VCAN Versican 1462 0.87 X 0.252
VTN Vitronectin 7448 0.62 ↓ 0.024
Mx3000p). The thermocycler profile setting was 10min at
95∘C for 1 cycle and 15 s at 95∘Cand 1min at 60∘C for 40 cycles.
The software was also programmed to do a melt or dissocia-
tion curve at the end of the run to ensure the amplification of
a single product for each gene.The threshold cycle (𝐶
𝑡
) values
were imported into an Excel spreadsheet (Available from
the SABiosciences website: http://www.sabiosciences.com/)
which normalised the results against the 5 housekeeping
genes (ACTB, B2M, GAPDH, HPRTI, and RPLPO). In
addition, the relative gene expression (ΔΔ𝐶
𝑡
) and fold change
(2−ΔΔ𝐶𝑡) were also calculated. Prior to data analysis, all the
𝐶
𝑡
values of the controls were examined to ensure proper
functioning of the PCR array and preceding steps (positive
PCR control, 𝐶
𝑡
value of 20 ± 2; genomic DNA control,
𝐶
𝑡
value of >35). A fold change of >1 was reported as fold
upregulation and a fold change <1 was reported as fold
downregulation.
2.6. Statistical Analysis. Experiments were repeated three
times (𝑛 = 3). Student’s 𝑡-test was analysed based on the
replicate fold change for each gene in both the test and
the control groups by the SABiosciences Excel-based data
analysis template and reported as significant if 𝑃 < 0.05.
Results are represented in Tables 3 to 6.
3. Results
Irradiation of N cells with 660 nm resulted in the significant
upregulation of 29 genes and downregulation of 19 genes
(Table 3). Irradiation of NW cells with 660 nm resulted in
the significant upregulation of 32 genes and downregulation
of 6 genes (Table 4). Irradiation of DW cells with 660 nm
resulted in the upregulation of 18 genes and downregulation
of 31 genes (Table 5). A summary of the results is presented in
Table 6.
4. Discussion and Conclusion
ECM components are very useful in different aspects of
wound healing. The ECM interacts with various cells and
growth factors in cell proliferation, influencing migra-
tion, cell differentiation, and regulating several biological
responses [1, 5, 6, 29, 30]. The effects shown by different
ECM components depend on the stage of the wound and are
determined by the interactions between the cells and growth
factors [29]. There is great need for gene expression profiling
in the ECM following laser irradiation to be exploited. In
this study, 84 genes related to the ECM were studied in
various models. Photoirradiation was shown to stimulate
gene expression 48 h after incubation in irradiated N, NW,
and DW cells as compared to their respective controls. The
genes, either up- or downregulated, are functionally grouped
depending on their pathways in the ECM.
In the present study, four main CAM families were medi-
ated following irradiation at 660 nm.They include cadherins,
integrins, selectins, and immunoglobulin CAM (Ig-CAM).
The cadherin family aremainly calcium-dependent glycopro-
teins containing an extracellular domain, a transmembrane
domain, and an intracellular domain [31]. Cadherins and
integrins form the main cell-surface transmembrane recep-
tors and are involved in modulating cell-cell and cell-matrix
adhesion. They function in various cellular events, namely,
cell migration, proliferation, survival, differentiation, and
modulation of gene expression profiling [32, 33]. In irradiated
N cells, CTNND2 was upregulated and CDH1, CTNNA1,
and CTNND1 were downregulated at 660 nm; irradiated
NW cells showed downregulation of CTNND2; and DW
cells showed an upregulation of CDH1 and CTNND2, while
CTNND1 was downregulated.
Integrins are the main receptor family in charge of
interactions in the ECM and consist of two noncovalent 𝛼
and 𝛽 subunits; the specific combination of the subunits
determines the degree of cell signalling [34]. In irradiated N
cells, ITGA1, ITGA3, ITGA5, and ITGAM were upregulated;
in irradiated NW cells, ITGA1, ITGA5, ITGA6, ITGA8,
ITGAL, ITGAM, ITGAV, and ITGB3 were upregulated; and
in irradiated DW cells, ITGA8, ITGAL, and ITGB3 were
upregulated, while ITGA2, ITGA3, ITGA5, ITGA6, ITGB1,
and ITGB4 were downregulated.
Selectins consist of an extracellular domain with a
calcium-dependent lectin domain, an epidermal growth
factor domain, and a hydrophobic transmembrane domain
[35, 36]. Selectins expressed in response to laser irradiation
in N cells included CLEC3B, while NW cells showed an
upregulation in SELE, SELL, and SELP and in DW cells there
was an upregulation in SELL.
Ig-CAM contains an extracellular domain with FN
repeats, a transmembrane domain, and an intracellular
domain [31, 35]. These domains bind with proteins of the
ECM, namely, collagen, LMN, and FN, as well as certain inte-
gral cell-surface proteins [31].Members of the Ig-CAM family
expressed in response to LILI were CD44, FN1, NCAM1,
PECAM1, SGCE, THBS1, THBS2, SPP1, VTN, VCAM1, and
CNTN1. In irradiated N cells, CD44, FN1, NCAM1, THBS1,
and THBS2 were upregulated, while SGCE, VCAM1, and
SPP1 were downregulated following irradiation at 660 nm as
compared to nonirradiated N cells. In irradiated NW cells,
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Table 5: Gene expression profile in diabetic wounded (DW) cells irradiated at 660 nm. Total RNA fromnonirradiatedDWcells and irradiated
DW cells were characterised in triplicate. A fold difference >1 is considered as gene upregulation, while a fold difference <1 is considered as
gene downregulation. Fold differences are indicated as upregulation (↑) or downregulation (↓). X denotes the nonsignificant genes in that
particular cell model.
Gene symbol Gene description Gene ID Fold difference Up/downregulation P value
ADAMTS1 ADAMmetallopeptidase with thrombospondin type 1motif, 1 9510 0.50 ↓ 0.003
ADAMTS13 ADAMmetallopeptidase with thrombospondin type 1motif, 13 11093 0.91 X 0.589
ADAMTS8 ADAMmetallopeptidase with thrombospondin type 1motif, 8 11095 2.75 ↑ 0.005
CD44 CD44 molecule (Indian blood group) 960 0.53 ↓ 0.049
CDH1 Cadherin 1, type 1, E-cadherin (epithelial) 999 2.12 ↑ 0.051
CLEC3B C-type lectin domain family 3, member B 7123 1.14 X 0.749
CNTN1 Contactin 1 1272 2.19 ↑ 0.041
COL11A1 Collagen, type XI, alpha 1 1301 3.68 ↑ 0.002
COL12A1 Collagen, type XII, alpha 1 1303 0.37 X 0.003
COL14A1 Collagen, type XIV, alpha 1 7373 1.24 ↑ 0.023
COL15A1 Collagen, type XV, alpha 1 1306 0.67 X 0.082
COL16A1 Collagen, type XVI, alpha 1 1307 0.61 ↓ 0.001
COL1A1 Collagen, type I, alpha 1 1277 0.87 X 0.498
COL4A2 Collagen, type IV, alpha 2 1284 0.99 X 0.966
COL5A1 Collagen, type V, alpha 1 1289 0.56 ↓ 0.036
COL6A1 Collagen, type VI, alpha 1 1291 0.64 ↓ 0.015
COL6A2 Collagen, type VI, alpha 2 1292 0.58 ↓ 0.014
COL7A1 Collagen, type VII, alpha 1 1294 0.36 ↓ 0.017
COL8A1 Collagen, type VIII, alpha 1 1295 0.71 X 0.271
CTGF Connective tissue growth factor 1490 1.10 X 0.521
CTNNA1 Catenin (cadherin-associated protein), alpha 1, 102 kDa 1495 0.83 X 0.340
CTNNB1 Catenin (cadherin-associated protein), beta 1, 88 kDa 1499 0.64 X 0.084
CTNND1 Catenin (cadherin-associated protein), delta 1 1500 0.36 ↓ 0.005
CTNND2 Catenin (cadherin-associated protein), delta 2 (neuralplakophilin-related arm-repeat protein) 1501 2.72 ↑ 0.052
ECM1 Extracellular matrix protein 1 1893 0.74 X 0.076
FN1 Fibronectin 1 2335 0.58 ↓ 0.008
HAS1 Hyaluronan synthase 1 3036 0.87 X 0.544
ICAM1 Intercellular adhesion molecule 1 3383 0.97 X 0.843
ITGA1 Integrin, alpha 1 3672 0.97 X 0.721
ITGA2 Integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2receptor) 3673 0.52 ↓ 0.015
ITGA3 Integrin, alpha 3 (antigen CD49C, alpha 3 subunit ofVLA-3 receptor) 3675 0.50 ↓ 0.010
ITGA4 Integrin, alpha 4 (antigen CD49D, alpha 4 subunit ofVLA-4 receptor) 3676 0.86 X 0.459
ITGA5 Integrin, alpha 5 (fibronectin receptor, alphapolypeptide) 3678 0.54 ↓ 0.004
ITGA6 Integrin, alpha 6 3655 0.76 ↓ 0.012
ITGA7 Integrin, alpha 7 3679 1.11 X 0.513
ITGA8 Integrin, alpha 8 8516 2.75 ↑ 0.051
ITGAL Integrin, alpha L (antigen CD11A (p180), lymphocytefunction-associated antigen 1; alpha polypeptide) 3683 3683 1.89 ↑ 0.003
ITGAM Integrin, alpha M (complement component 3 receptor 3subunit) 3684 1.77 X 0.065
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Table 5: Continued.
Gene symbol Gene description Gene ID Fold difference Up/downregulation P value
ITGAV Integrin, alpha V (vitronectin receptor, alphapolypeptide, antigen CD51) 3685 0.50 ↓ 0.002
ITGB1 Integrin, beta 1 (fibronectin receptor, beta polypeptide,antigen CD29 includes MDF2, MSK12) 3688 0.53 ↓ 0.005
ITGB2 Integrin, beta 2 (complement component 3 receptor 3and 4 subunit) 3689 1.58 X 0.083
ITGB3 Integrin, beta 3 (platelet glycoprotein IIIa, antigenCD61) 3690 0.58 ↓ 0.006
ITGB4 Integrin, beta 4 3691 1.87 ↑ 0.041
ITGB5 Integrin, beta 5 3693 0.97 X 0.879
KAL1 Kallmann syndrome 1 sequence 3730 0.41 ↓ 0.001
LAMA1 Laminin, alpha 1 284217 0.60 ↓ 0.014
LAMA2 Laminin, alpha 2 3908 1.17 X 0.396
LAMA3 Laminin, alpha 3 3909 2.25 ↑ 0.031
LAMB1 Laminin, beta 1 3912 0.95 X 0.609
LAMB3 Laminin, beta 3 3914 0.61 ↓ 0.010
LAMC1 Laminin, gamma 1 (formerly LAMB2) 3915 0.54 ↓ 0.008
MMP1 Matrix metallopeptidase 1 (interstitial collagenase) 4312 0.38 ↓ 0.001
MMP10 Matrix metallopeptidase 10 (stromelysin 2) 4319 1.28 X 0.271
MMP11 Matrix metallopeptidase 11 (stromelysin 3) 4320 1.71 ↑ 0.025
MMP12 Matrix metallopeptidase 12 (macrophage elastase) 4321 0.52 ↓ 0.005
MMP13 Matrix metallopeptidase 13 (collagenase 3) 4322 1.89 ↑ 0.034
MMP14 Matrix metallopeptidase 14 (membrane-inserted) 4323 0.44 ↓ 0.016
MMP15 Matrix metallopeptidase 15 (membrane-inserted) 4324 1.24 X 0.157
MMP16 Matrix metallopeptidase 16 (membrane-inserted) 4325 0.44 ↓ 0.003
MMP2 Matrix metallopeptidase 2 (gelatinase A, 72 kDagelatinase, 72 kDa type IV collagenase) 4313 0.54 ↓ 0.002
MMP3 Matrix metallopeptidase 3 (stromelysin 1, progelatinase) 4314 2.42 ↑ 0.009
MMP7 Matrix metallopeptidase 7 (matrilysin, uterine) 4316 1.86 ↑ 0.024
MMP8 Matrix metallopeptidase 8 (neutrophil collagenase) 4317 0.63 ↓ 0.029
MMP9 Matrix metallopeptidase 9 (gelatinase B, 92 kDagelatinase, 92 kDa type IV collagenase) 4318 1.47 ↑ 0.009
NCAM1 Neural cell adhesion molecule 1 4684 0.97 X 0.811
PECAM1 Platelet/endothelial cell adhesion molecule 5175 3.66 X 0.213
SELE Selectin E 6401 1.50 X 0.078
SELL Selectin L 6402 2.36 ↑ 0.013
SELP Selectin P (granule membrane protein 140 kDa, antigenCD62) 6403 1.90 X 0.249
SGCE Sarcoglycan, epsilon 8910 0.93 X 0.657
SPARC Secreted protein, acidic, cysteine-rich (osteonectin) 6678 0.66 ↓ 0.054
SPG7 Spastic paraplegia 7 (pure and complicated autosomalrecessive) 6687 0.48 ↓ 0.005
SPP1 Secreted phosphoprotein 1 6696 0.58 ↓ 0.009
TGFBI Transforming growth factor, beta-induced, 68 kDa 7045 0.79 X 0.099
THBS1 Thrombospondin 1 7057 0.35 ↓ 0.001
THBS2 Thrombospondin 2 7058 0.81 X 0.088
THBS3 Thrombospondin 3 7059 1.03 X 0.794
TIMP1 TIMP metallopeptidase inhibitor 1 7076 1.47 ↑ 0.046
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Table 5: Continued.
Gene symbol Gene description Gene ID Fold difference Up/downregulation P value
TIMP2 TIMP metallopeptidase inhibitor 2 7077 0.93 X 0.788
TIMP3 TIMP metallopeptidase inhibitor 3 7078 1.05 X 0.825
TNC Tenascin C 3371 1.18 X 0.492
VCAM1 Vascular cell adhesion molecule 1 7412 1.79 ↑ 0.002
VCAN Versican 1462 0.96 X 0.775
VTN Vitronectin 7448 1.20 X 0.240
FN1, PECAM1, THBS1, and THBS2 were upregulated, while
SGCE and VTN were downregulated at 660 nm as compared
to nonirradiated N cells. In irradiated DW cells, CNTN1
and VCAM1 were upregulated, while CD44, FN1, THBS1,
and SPP1 were downregulated at 660 nm as compared to
nonirradiatedDWcells. Other adhesionmolecules expressed
in response to LILI were HAS1, VCAN, TNC, KAL1, and
CTGF. In this study, KAL1 was upregulated while TNC,
VCAN, and CTGF were downregulated in irradiated N cells.
In irradiated NW cells, HAS1 and KAL1 were upregulated
and TNC was downregulated. In irradiated DW cells, KAL1
was upregulated at 660 nmas compared to nonirradiatedDW
cells.
ECM proteins including collagen, LMN, EI, proteogly-
cans, and FN have both adhesive and structural functions.
The ECM maintains skin integrity and homeostasis and
interacts with several structural and extracellular proteins.
Collagen is encoded for by more than 42 genes [29, 37].
Some of the collagen molecules are formed through the
interaction between FN and integrins [38, 39]. Collagens
are extracellular proteins produced mainly by fibroblasts,
divided into two main classes, namely, the nonfibril forming
(collagens types IV, VI, VII, and XI) and the fibril forming
collagens distinguished by their triple helix (collagens types
I, II, III, V, and XI). Their main function is to maintain the
structural integrity of various tissues and to strengthen and
reorganise the ECM [40]. In this study, COL1A1, COL4A2,
COL5A1, COL6A1, COL6A2, COL8A1, and COL12A1 were
upregulated in irradiated N cells. In irradiated NW cells,
COL1A1, COL5A1, COL7A1, COL8A1, and COL12A1 were
upregulated, while in DW cells COL11A1 and COL14A1
were upregulated and COL5A1, COL6A1, COL6A2, COL7A1,
COL12A1, and COL16A1 were downregulated.
LMNs are basementmembrane proteinsmade up of three
nonidentical chains. They are associated with cell adhesion,
differentiation, migration, matrix organisation, and signal
transduction. LAMA1 was upregulated in irradiated N cells,
while LAMA2 and LAMA3 were downregulated. In irradi-
atedDWcells LAMA3was upregulated andLAMA1, LAMB3,
and LAMC1 were downregulated. Other matrix associated
proteins, such as secreted protein, acidic, and cysteine-rich
(encoded for by SPARC), spastic paraplegin 7 (encoded for by
SPG7), and extracellularmatrix protein 1, were also evaluated.
SPARC is associated with cell structure organisation, cell
migration, and ECM synthesis [41, 42]. SPG7 is involved in
the breakdown of incorrectly folded proteins intracellular
motility,membrane trafficking, and organelle biogenesis [43].
ECM1 is part of a cluster of genes involved in epidermal
differentiation. Irradiation of N and NW cells to 660 nm
resulted in an upregulation of SPARC and SPG7 and a
downregulation in ECM1. Analysis of the gene profile of
irradiated DW cells revealed a significant downregulation of
SPARC and SPG7. Significantly increased gene expression of
the constituents of the basement membrane was observed at
660 nm inN andNWcells, while DWcells showed a decrease
in gene regulation, with most of the genes downregulated.
MMPs are metalloproteases involved in the degradation
of the ECM and can be affected in normal or patholog-
ical tissue remodelling and wound healing with different
substrates, mostly collagen. MMPs are inhibited by TIMPs.
ADAMTS (a disintegrin and metalloproteinase with throm-
bospondin motifs) is a family of 19 peptidases that are
involved in the processing of procollagen, connective tissue
organization, and cell migration [44–48]. The gene profile
for ECM proteases and inhibitors in response to irradiation
at 660 nm revealed an upregulation in MMP2, MMP11,
MMP14, MMP15, ADAMTS1, ADAMTS8, TIMP1, TIMP2,
and TIMP3 and a downregulation in MMP1, MMP3, MMP7,
MMP9, MMP12, and MMP13 in N cells. Irradiated NW
cells showed an upregulation of MMP2, MMP8, MMP11,
MMP15, ADAMTS1, ADAMTS8, and ADAMTS13, while
MMP1, MMP3, and MMP12 showed a downregulation as
compared to nonirradiated N cells. In irradiated DW cells,
MMP3, MMP7, MMP9, MMP11, MMP13, ADAMTS8, and
TIMP1 were upregulated, while ADAMTS1, MMP1, MMP2,
MMP12, MMP14, and MMP16 were downregulated as com-
pared to nonirradiated DW cells.
These results demonstrated changes in gene expression
within the different irradiated N, NW, and DW cell models.
The genetic profile seen in the N cell model is a normal
response of fibroblast cells to laser irradiation at 660 nm
with 5 J/cm2. On the other hand, cells in the NW and DW
models have been stressed and compromised in some way,
and the genetic profile seen in these cells is a response
of wounded/stressed fibroblast cells to laser irradiation at
660 nm.Mechanicalmodulation of these cells would increase
upregulation of ECM components, ECM-specific receptors,
and enhanced expression of several cytokines and growth
factors in a time-dependent manner [49–51]. The present
study showed that DW cells had a significantly downregu-
lated gene expression profile as compared to N and NW cells
when irradiated at 660 nm. The downregulation of most of
the genes in DW cells is probably due to the dysfunctioning
of the ECM exhibited in chronic wounds as a result of
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hyperglycaemia. Also in chronic wounds, the inflammatory
phase is normally delayed, which promotes increased levels
of proteases such as MMPs, causing destruction of the ECM,
and damages growth factors as well as receptors essential in
the healing process. This also results in a lack of integrins
which bind to FN to enhance migration, and hence the
decrease in migration [52, 53]. Furthermore MMP3, MMP7,
MMP9, MMP11, and MMP13 were upregulated in DW
cells irradiated at 660 nm. This is possibly due to the fact
that degraded collagen molecules do not interact properly
enabling a disorganised and weak ECM, increasing the levels
of some MMPs in chronic wounds [54]. This corresponds
with the decrease in Col-I seen in these cells [21]. However,
there was a significant upregulation of some of the collagens
and other essential ECM proteins, which is in line with the
increase in collagen seen in irradiated DW cells [20].
In conclusion, photobiomodulation at a wavelength of
660 nm enhances gene expression of proteins involved in the
ECM.The profile is dependent on the culture conditions and
stressors placed on the cells. Increased glucose concentration
in the culture media was associated with impaired gene
regulation, which could be accountable for the poor response
of these cells seen in wound healing. Previous studies have
not exploited the role of LILI in gene expression of proteins
in the ECM using fibroblast cells in vitro. This study was
able to show the gene profile in normal and diabetic wound
healing in vitro. The results also confirm the very important
role exhibited by cell adhesion molecules (CAMs), integrins,
ECM proteins, proteases, and inhibitors in wound healing.
Therefore LILI mediated gene expression in wounded fibrob-
lasts through paracrine and autocrine interactions to enhance
wound healing. Further work on the molecular advances
of gene modulation and their receptors will elucidate the
therapeutic importance of LILI.
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